A PHASE 1,0PEN-LABEL,DOSEESCALATING STUDYEVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF THE COMBINATION OF CLBROOI, AN ENGINEERED AUTOLOGOUS T-CELLPRODUCT,ANDSWI019,AN ANTIBODY-BASED BIOLOGIC, IN PATIENT
|Effective start/end date||8/19/20 → 8/30/25|
- SCRIPPS RESEARCH INSTITUTE DBA CALIBR
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.